World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
28212
World Ranking
18288
National Ranking
70

Overview

Won Ki Kang is affiliated with Samsung Medical Center in South Korea and has a research focus primarily within the field of Medicine. Their published work spans subfields including Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research, and Molecular Biology.

Their recent scientific contributions include studies in gastric cancer and immunotherapy with the following notable papers:

  • "A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial" (2020), published in Annals of Oncology
  • "Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer" (2021), published in Cancer Discovery
  • "Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab" (2021), published in Gastric Cancer
  • "Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer" (2020), published in Frontiers in Oncology
  • "Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer" (2020), published in Translational Cancer Research

Won Ki Kang often publishes in journals with a clinical oncology focus. Frequent publication venues include:

  • Journal of Clinical Oncology
  • Therapeutic Advances in Medical Oncology
  • Annals of Oncology
  • Gastric Cancer
  • Cancers

The scientist's collaborative network is notable, with frequent coauthors including:

  • Jeeyun Lee
  • Seung Tae Kim
  • Jung Yong Hong
  • Ho Yeong Lim
  • Joon Oh Park

Research topics covered extensively by Won Ki Kang encompass:

  • Gastric Cancer Management and Outcomes
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Treatments and Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Gastrointestinal Tumor Research and Treatment
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics

Best Publications

  • Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

    Yoon Koo Kang;Narikazu Boku;Taroh Satoh;Min Hee Ryu

  • Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

    Razvan Cristescu;Jeeyun Lee;Michael Nebozhyn;Kyoung-Mee Kim

  • Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

    Seung Tae Kim;Razvan Cristescu;Adam J. Bass;Kyoung Mee Kim

  • Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

    Jung Hun Kang;Soon Il Lee;Do Hyoung Lim;Keon Woo Park

  • Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial

    Jeeyun Lee;Do Hoon Lim;Sung Kim;Se Hoon Park

  • Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

    Jeeyun Lee;Se Hoon Park;Heung Moon Chang;Jun Suk Kim

  • Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses

    Se Hoon Park;Tae Sung Sohn;Jeeyun Lee;Do Hoon Lim

  • Clinical significance of four molecular subtypes of gastric cancer identified by The Cancer Genome Atlas project

    Bo Hwa Sohn;Jun Eul Hwang;Hee Jin Jang;Hee Jin Jang;Hyun Sung Lee

  • An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

    Sung Kim;Do Hoon Lim;Jeeyun Lee;Won Ki Kang

  • Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.

    Filippo Pietrantonio;Rosalba Miceli;Alessandra Raimondi;Young Woo Kim

  • The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma

    Sarah Park;Jeeyun Lee;Young Hyeh Ko;Arum Han

  • Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype

    Sang Cheul Oh;Sang Cheul Oh;Bo Hwa Sohn;Jae Ho Cheong;Sang Bae Kim

  • Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria

    Joon Oh Park;Soon I. I. Lee;Seo Young Song;Kihyun Kim

  • Safety and efficacy of nivolumab in combination with s-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (attraction-4)

    N. Boku;M.-H. Ryu;K. Kato;H.C. Chung

  • CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

    W. S. Kim;S.-Y. Song;Y. C. Ahn;Y.-H. Ko

  • Phase II study of sunitinib as second-line treatment for advanced gastric cancer

    Yung Jue Bang;Yoon Koo Kang;Won K. Kang;Narikazu Boku

  • Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas

    Suling J. Lin;Johann A Gagnon-Bartsch;Iain Beehuat Tan;Sophie Earle

  • Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.

    Jeeyun Lee;Yeon Hee Park;Won Seog Kim;Seung-Sook Lee

  • Malignant obstruction of gastric outlet and duodenum: palliation with flexible covered metallic stents.

    Kwang Bo Park;Young Soo Do;Won Ki Kang;Sung Wook Choo

  • A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

    Li Tzong Chen;Taroh Satoh;Min Hee Ryu;Yee Chao

Frequent Co-Authors

Jeeyun Lee
Jeeyun Lee Sungkyunkwan University
Joon Oh Park
Joon Oh Park Samsung Medical Center
Ho Yeong Lim
Ho Yeong Lim Samsung Medical Center
Keunchil Park
Keunchil Park The University of Texas MD Anderson Cancer Center
Se-Hoon Lee
Se-Hoon Lee Sungkyunkwan University
Yoon-Koo Kang
Yoon-Koo Kang Asan Medical Center
Jin Seok Ahn
Jin Seok Ahn Sungkyunkwan University
Ki-Hyun Kim
Ki-Hyun Kim Hanyang University
Woong-Yang Park
Woong-Yang Park Samsung Medical Center
Narikazu Boku
Narikazu Boku St. Marianna University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives to the traditional path of studying medicine in the USA can open diverse career opportunities in healthcare. Prospective students often seek faster or more affordable ways to enter or advance in the field. For those interested in nursing, a 6 month lpn program offers a quick route to becoming a Licensed Practical Nurse, providing hands-on experience and a foundation for further education.

If you already hold a nursing degree, the fastest psych np program can help you specialize in psychiatric-mental health, responding to a rising demand for mental health professionals. Meanwhile, those interested in healthcare leadership might consider an online healthcare administration degree, which covers organizational, financial, and strategic aspects of healthcare services.

For experienced professionals aiming for executive roles, the cheapest mha online programs provide a cost-effective way to earn a respected advanced degree. These flexible online options make it easier to balance studies with work or family commitments, helping you accelerate your career in the dynamic healthcare sector.

Best Scientists Citing Won Ki Kang

Trending Scientists

Recently Published Articles